Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
393.1 USD | -0.27% | -1.13% | -3.39% |
20:03 | VERTEX PHARMACEUTICALS INCORPORATED : UBS behält seine Kaufempfehlung bei | ZM |
15:12 | VERTEX PHARMACEUTICALS INCORPORATED : Guggenheim gibt eine Kauf-Bewertung ab | ZM |
ETFs investiert in Vertex Pharmaceuticals Incorporated
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
7,67% | 0 M€ | 0.00% | - | |
7,08% | 0 M€ | 0.00% | - | |
5,20% | 2 M€ | -.--% | ||
4,81% | 7 M€ | -.--% | - | |
4,05% | 115 M€ | +5.58% | - | |
3,53% | 1 M€ | -1.52% | - | |
2,32% | 2 M€ | +6.77% | ||
2,28% | 8 M€ | -.--% | ||
1,99% | 12 M€ | +15.09% | - | |
1,93% | 1 M€ | 0.00% | - | |
1,71% | 2 M€ | -25.75% | ||
1,63% | 18 M€ | +2.84% | - | |
1,61% | 267 M€ | +4.66% | ||
1,58% | 9 M€ | -4.31% | - | |
1,10% | 204 M€ | +10.54% | ||
1,06% | 1 182 M€ | -0.79% | ||
0,87% | 9 M€ | -.--% | - | |
0,82% | 13 M€ | -.--% | - | |
0,82% | 3 M€ | +15.16% | - | |
0,82% | 4 M€ | -.--% | - | |
0,81% | 26 M€ | +16.85% | - | |
0,73% | 22 M€ | 0.00% | - | |
0,69% | 5 M€ | -72.95% | - | |
0,68% | 3 M€ | 0.00% | - | |
0,51% | 717 M€ | +4.93% |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-3.39% | 102 Mrd. | |
+2.61% | 96.09 Mrd. | |
-1.02% | 22.05 Mrd. | |
-18.14% | 20.81 Mrd. | |
-6.87% | 19.06 Mrd. | |
-40.70% | 16.05 Mrd. | |
-26.89% | 14.01 Mrd. | |
+1.12% | 13.38 Mrd. | |
+22.25% | 11.01 Mrd. | |
-18.85% | 9.12 Mrd. |
- Börse
- Aktien
- 882807 Aktie
- ETFs Vertex Pharmaceuticals Incorporated